| 存貨編碼 | 名稱 | 單字母序列 | 規(guī)格 | 純度 |
|---|---|---|---|---|
| α-CGRP (23-37) (human) | VKNNFVPTNVGSKAF-NH2 | 1mg,5mg,10mg,50mg,100mg,1g | 80%,90%,95%,98%,99% | |
| H-Val-Gly-Ser-Glu-OH | VGSE | 1mg,5mg,10mg,50mg,100mg,1g | 80%,90%,95%,98%,99% | |
| α-CGRP (32-37) (canine, mouse, porcine, rat) | VGSEAF-NH2 | 1mg,5mg,10mg,50mg,100mg,1g | 80%,90%,95%,98%,99% | |
| H-Val-Gly-Asp-Glu-OH | VGDE | 1mg,5mg,10mg,50mg,100mg,1g | 80%,90%,95%,98%,99% | |
| Experimental Autoimmune Encephalomyelitis Complementary Peptide | VFILGPLRLLG | 1mg,5mg,10mg,50mg,100mg,1g | 80%,90%,95%,98%,99% | |
| A-VI-5 | VESSK | 1mg,5mg,10mg,50mg,100mg,1g | 80%,90%,95%,98%,99% | |
| p60 v-src (137-157) | VAPSDSIQAEEWYFGKITRRE | 1mg,5mg,10mg,50mg,100mg,1g | 80%,90%,95%,98%,99% | |
| Grb2 SH2 Domain Ligand | (p-Y)VNV | 1mg,5mg,10mg,50mg,100mg,1g | 80%,90%,95%,98%,99% |
